the - 医索

找到约 965 条结果

A Randomized, Multicenter, Open-label, Phase lll Trial ComparingAnthracyclines Followed by Taxane Versus Anthracyclines Followedby Taxane Plus Carboplatin as (Neo) Adjuvant Therapy in Patientswith

医客学院 - 会议报告集

slides-The_impact_of_adjuvant_endocrine_therapy_AET_omiss

医客学院 - 会议报告集

STRIKING THE BALANCE WITH NEXTGENERATION TARGETED THERAPIESFOR ALK AND EGFR

医客学院 - 会议报告集

Sparking the ConversationIntegrating ctDNA and Quality ofLife in Adjuvant Lung Cancer Care

医客学院 - 会议报告集

slides-Overall_survival_of_adebrelimab_plus_chemotherapy_.

医客学院 - 会议报告集

Sacituzumab Tirumotecan (sac-TMT; Also Known asSKB264MK-2870)in Combination With KL-A167 (Anti-PD-L1)as First-Line Treatment for Patients With Advanced NSCLCFrom the Phase ll OptiTRoP-Lung01 Study

医客学院 - 会议报告集

NRG-LU002Randomized Phase lllll Trial Of MaintenanceSystemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer

医客学院 - 会议报告集

Niraparib and Dostarlimab efficacy in patients with platinum.sensitive relapsed mesothelioma MlST5, a phase lla clinicaltrial

医客学院 - 会议报告集

Neoadjuvant nivolumab plus chemotherapy vschemotherapy in patients with resectable NSCLC4-year update from CheckMate 816

医客学院 - 会议报告集

Molecular residual disease analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR-mutated stage lB-lllA non-small cell lung cancer

医客学院 - 会议报告集

今日实时热搜